A parametric method of statistical analysis for dilution assays is developed in detail from first principles of probability and statistics. The method is based on a simple product binomial model for the experiment and produces an estimate for the concentration of target entities, a confidence interval for this concentration, and an indicator of the quality of the assay called the p value for goodness of fit. The procedure is illustrated with data from a virologic quantitative micrococulture assay used to quantify free human immunodeficiency virus in clinical trials. The merits of the procedure versus those of nonparametric methods of estimating the dilution inducing a 50% response rate are discussed. Advantages of the proposed approach include plausibility of the underlying assumptions, ability to assess plausibility of specific experimental outcomes through their likelihood, and plausibility of confidence intervals.
A dilution assay is an experiment for estimating the concentration or frequency of target entities in a sample, in situations in which accurate counts of the organism are too difficult or costly to obtain. The original sample is divided into subsamples at lower concentrations by dilution. These subsamples may be further sampled to obtain replicate plates, tubes, or wells at each concentration level. Each replicate is then scored for the presence or absence of the target entity. This determination of positivity or negativity of each replicate may require an auxiliary test or procedure. For instance, the presence of bacteria may be deduced from the appearance of colonies after plates have been incubated for a time. In one example that motivated this work, it is desired to estimate the concentration of human immunodeficiency virus type 1 (HIV-1) p24 antigen-producing HIV-infected peripheral blood mononuclear cells (PBMCs) in a blood sample from a patient. Positivity is based on p24 antigen assay results obtained after 2 weeks of incubation. For our purposes, the key features of a dilution assay are that the sample is tested at certain dilutions and that the basic summary of each replicate is dichotomous or binary, with 1 representing a positive result and 0 a negative result.
The idea of a dilution assay is to choose a sufficiently broad range of dilutions that a transition from positive to negative results is virtually ensured as one proceeds through the dilution sequence. The dilutions at which the transition occurs contain information on the concentration of target entities in the original sample. We take estimation of this concentration as the primary purpose of the assay.
Dilution assays are widely used in microbiology, for instance, in the fields of public health (1) , virology (9) , and immunology (16) . A common practical application is to estimate the density of coliform bacteria in water samples. We have encountered several different dilution assays in our work with the National Institute of Allergy and Infectious Diseases AIDS Virology Quality Control Program for virology laboratories serving the AIDS Clinical Trials Group. Specific cases include quantitative micrococulture, plasma viremia, and neutralization assays (9) . based on a simple probability model for experimental results. The method produces an estimate of the concentration of target entities, a confidence interval for this concentration, and an indicator of the quality of the assay called the p value for goodness of fit (PGOF). In describing the method, we briefly review some fundamentals of probability and statistics, including the likelihood function as a basis for inference. We also compare the proposed parametric approach with competing nonparametric methods, such as that of Spearman and Karber and that of Reed and Muench, and indicate why we prefer the proposed approach.
Our statistical approach is developed in Materials and Methods, the first section of which establishes some notation and terminology and describes a virologic quantitative micrococulture example of dilution assays which is used to quantify free or blood-borne HIV in AIDS patients. The (xe,) of positive wells at the dth dilution level is the sum of the binary indicators at that level, e.g.,xI = w11 + w12,,X = w2l + w22, and so on. In this way, the QMC sample space can be viewed as the set of all ternary sextuples (xI, x2, x3, X4, X5, X6), where x,, is the number of positive wells among the duplicates at the dth dilution level (xd = 0, 1, or 2). The reduced sample space for the QMC assay contains 3" (=729) possible outcomes. Specific numeric outcomes will be written without parentheses and commas. For instance, 210000 indicates that both wells are positive at the first level, one of two wells is positive at the second level, and all wells are negative at lower levels.
(ii) Probability. Three properties are sufficient to define a probability function (p) on a finite sample space: P1, the probability [p(A)] of any event (A) is between 0 and 1; P2, the probability of the whole sample space is 1; P3, if A and B are events with no outcomes in common, then the probability that either event occurs is the sum of their individual probabilities [p(A or B) = p(A) + p(B)]. Events A and B with no outcomes VOL. 32, 1994 in common are called mutually exclusive; the occurrence of either event precludes the occurrence of the other event.
P3 is the addition rule for probability and extends in an obvious way to a finite number of mutually exclusive events, such as distinct individual outcomes.
The multiplication rule of probability is related to the notion of statistical independence. Events A and B are said to be independent if p (A and B) = p (A) p (B).
(1) (iii) Likelihood. To apply probability models to experimental data, it is useful to extend the probability notation to explicitly display dependence on a parameter such as the concentration of target entities. Let p(A Ic) [or p(ylc)] denote the probability of event A [or outcome (y)], assuming that c is the true concentration of target entities. (Strictly speaking, we should write p({y}lc) instead of p(ylc), since probability is a function of events and events are sets. } A mathematical model forp(ylc) is derived from equation 1 and P3 in the section on the probability model below.
Two distinct terms, probability and likelihood, can be applied to the function p(ylc), depending on the situation and perspective. In common parlance, these terms are synonymous, but in the domains of probability and statistics, an important distinction exists between them. If the state of nature or true concentration (c) is fixed and the outcome (y) is viewed as varying over the sample space, then p(ylc) is called probability. For the statistical perspective, at hand is a particular experimental outcome (y), and we want to draw inferences about the true concentration of target entities. Following R. A. Fisher (6), attention is directed to the likelihood function, which is the same function, p(ylc), but with outcome y fixed and parameter c varying.
Probability model. The purpose of this section is to develop a simple product binomial model for the likelihood, summarized in equations 3 and 4 below, used to calculate the probability of any dilution assay outcome for a given design and a given value of C (or IUPM). The development is an elaboration of Cochran (2) and uses only elementary probability.
(i) Coin tossing. Suppose we have a possibly biased coin with probability p of falling heads and probability q = 1 -p of falling tails. For any positive integer n, let n! equal the n-fold product of all integers from n down to 1 [n! = n (n -1) * (n -2) * ... .3 * 2 -1] and define 0! as 1. Then the probability of exactly k heads in n independent tosses of the coin is the binomial probability
The derivation is straightforward if it is assumed that the tosses are independent and equation 1 and P3 are used. It follows from equation 1 that any particular sequence of n tosses with exactly k heads and n -k tails has probability pk * qn k, and the factorial term in braces is simply the number of such sequences.
(ii) Probability model for a single dilution. Consider a dilution assay with n replicates at a single dilution. Letf denote the fraction of the patient's total PBMC population which is tested in each replicate. If the patient harbors T target entities, then the probability that a given target entity is not in a given replicate is 1 -f and the probability that none of the T target entities is in a given replicate is q = (1 -f)T, according to equation 1. The probability of a negative replicate is q.
The following approximation is critical and implies that we do not need to knowf. By the first-order Taylor approximation exp (-J) 1 -f, for f near zero, q is closely approximated by exp (-f7 T), which can, in turn, be rewritten as exp ( -C * u), where C is the patient's concentration of target entities per PBMC and u is the number of PBMC per replicate.
By analogy with coin tossing, associating heads with positive and tails with negative, the probability that exactly k of the n replicates are positive and n -k are negative is given by equation 2 with q = 1 -p = exp(-C u).
(iii) Probability model for a general dilution assay. By the preceding argument, the probability that no target entities end up in a given well at the dth dilution level is approximately qd = exp (-C -Ud) (3) Thus, qd is the probability that a given well at the dth dilution level is negative, i.e., devoid of IUs and p24 antigen. Assuming further that all wells are independent, equation 1 Table 2 .
For any outcome y = (xl, x2, x3, X4, X5, X6), we want (i) an estimate of the IUPM in the original sample, (ii) a 95% confidence interval for IUPM, and (iii) an indicator of the quality of the data (x1, X2, x3, x4, x5, x6). We will approach these problems in the order of their complexity: i, iii, and ii.
(ii) Probability or likelihood matrix. The probability (or likelihood) matrix (P) is central to the statistical computation. In our formulation of the problem, both the sample space and the parameter space are finite sets. The lowest, the second highest as the second lowest, and so on. That is, the actual experimental outcome was 222101.
This illustrates how an explicit probability model can be used to advantage to identify unlikely outcomes for closer inspection and possible retesting.
In addition to PGOF, another natural indicator of assay quality might involve precision as expressed by the confidence interval width or the ratio of upper to lower confidence limits. In fact, the probability distribution of the MLE e is known to be skewed, while the distribution of the logarithm of e is much more symmetric and closer to normal (2) . This suggests that the difference between the logarithms of the confidence interval endpoints, or, equivalently, the ratio of the endpoints, is a reasonable summary of precision.
These two aspects of quality, PGOF and the ratio of confidence interval endpoints, are actually quite different.
Outcomes which are rarer in PGOF terms can be more informative in confidence interval terms. This is illustrated by comparison of the results in Table 4 for outcomes 210000 and 201000, which have respective PGOFs of 1.0 and 0.255 and respective confidence interval ratios of 21.6 and 15.1. This should not be interpreted as a commentary on the validity of the PGOF as an indicator of assay quality, and laboratories should not aspire to produce outcomes with low PGOFs.
DISCUSSION
The methodology presented here is applicable to any dilution assay producing binary (+/-or 1/0) data at the replicate level. We have illustrated the method in terms of a virologic quantitative micrococulture assay whose purpose is to quantify HIV in infected patients as IUPM. Application to other assays is straightforward, as long as they qualify as dilution assays with dichotomous outcomes. For instance, the plasma viremia assay (9) is similar to the QMC assay, employing duplicate wells at each of six fivefold dilutions, except that a fixed volume of patient plasma is input to the replicates at each level (0.4 ml at the first dilution level, 0.08 ml at the second level, 0.016 ml at the third level, and so forth.) In this case, Ud is defined as the volume of plasma at the dth level and the concentration (C) of target entities is defined relative to a unit volume of plasma equal to the volume input to a well at the first dilution level, i.e., 0.4 ml. The estimated concentration (C) will then be the number of lUs per 0.4 ml, which is multiplied by 2.5 to obtain the concentration ofIUs per milliliter. Neutralization assays are treated similarly.
Competitors to the parametric method of analysis based on the simple product binomial model include nonparametric procedures going under the names of Spearman and Karber, Reed and Muench, Dragstedt and Behrens, Litchfield and Wilcoxon and moving average methods (5, 8) . These methods might be applied to dilution assays to estimate the ED50, i.e., the dilution at which 50% of the replicates would be expected to be positive. Regarding the first three methods, in his classic work, Finney (reference 5, p. 394) opines the following. Finney (reference 5, p. 435) also asserts that the underlying assumptions are more realistic for the simple product binomial model than for the nonparametric approaches: "The reader is warned against attempting to use any analogue of the Dragstedt-Behrens, Reed-Muench or moving average method for dilution assays. The exponential formula for the probability of a sterile plate is not symmetric about any point, and these methods are even less appropriate than with normal or logistic sigmoid response curves."
It thus appears that the only serious competitor among these nonparametric methods of estimating the ED50 is the Spearman-Karber estimate. If the equation (3) for the probability of a positive response is accepted as a reasonable approximation, then the ED50 is that number of PBMC per well such that exp mutually exclusive events: a collection of events with the property that no two of the events have any outcomes in common; i.e., the occurrence of either event precludes the occurrence of the other event 95% confidence interval for a parameter: an interval produced by using a statistical recipe, such that the recipe has a probability of at least 0.95 of producing an interval containing the true parameter value (Any specific interval of numbers either contains or does not contain the true value, so it would not make sense to assert that the interval has a probability of 0.95 of containing the true value.) (null) hypothesis: a tentatively entertained statement about a parameter parameter: a number or vector which affects the distribution of probability, e.g., the probability of heads in coin tossing parameter estimate: a statistic whose purpose is to estimate a parameter PGOF: the probability of results as rare as or rarer than those obtained, assuming that the probability model is correct and the true parameter value is equal to its MLE probability: assignment of nonnegative numbers to events with the properties that the probability of the whole sample space is unity and the probability of a union of two mutually exclusive events is the sum of their individual probabilities p value for testing the simple hypothesis H that C = c0, given data yo and test statistic t: the probability of an outcome as extreme as or more extreme than that obtained, as determined by t(y), assuming that H is true, i.e., the probability that t(y) is less than or equal to t(yo) 
